A New Option for Uncontrollable Blood Pressure

When blood pressure cannot be lowered far enough with medications, renal denervation may be the next step.


In November 2023, the U.S. Food & Drug Administration approved two renal denervation systems for treating uncontrolled hypertension. Both systems use the same principal: By destroying nerves in the kidneys, they change the way the kidneys regulate blood pressure. Only the energy used to accomplish this task differs: The Paradise™ system uses ultrasound, and the Symplicity Spyral™ system utilizes radio­frequency energy.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access